Hemorrhoids and Bleeding on a GLP-1

The part that comes after the constipation

I would discuss constipation during GLP-1 treatment as its own symptom. If pain or bleeding appears too, I would not assume that constipation has already explained it.

If you are straining, or you have gone from daily to twice a week, or you have spent a genuinely undignified amount of time on the toilet lately, and now something hurts or you have seen blood on the paper: I would want an assessment rather than a reassuring guess.

I am going to be careful here, because when I read the research, the thing everybody says turned out not to be established — and the reassuring conclusion everybody jumps to is the one that could get you hurt.

Some links below are to programs we may earn a referral fee from. See our disclosure.

First, the sentence I need you to read twice

Here is the finding that changed how I think about this.

A review in Clinical Gastroenterology and Hepatology looked at what we actually know about hemorrhoids, and reported that the symptoms everyone attributes to them — bleeding, pain, itching, seepage, prolapse, mucus discharge — were reported equally by patients with and without hemorrhoids¹.

Read that again. The symptoms do not tell you whether you have hemorrhoids. Which means the reasoning almost all of us do — "I have been constipated, I am bleeding a little, it is obviously hemorrhoids" — is not a safe conclusion. It might be right. It is not something you can know from your own symptoms.

So the rule I would use: rectal bleeding gets looked at by a clinician. Every time. It is not a wait-and-see symptom, and it is not a "well, I have been constipated" symptom. Most of the time the answer will be boring and fixable. The point is that "most of the time" is not a diagnosis, and the boring answer is not the one you want to assume your way into.

Is it actually the constipation causing it?

This is where I expected a clean answer and did not get one. My two best sources do not fully agree, so here are both rather than the tidier one.

The 2019 review says the link is not proven. A low-fiber diet and constipation "have historically been thought to increase the risk for hemorrhoids, but not proven," and the review describes the whole etiology of hemorrhoids as speculative¹. It also points out how little research this has attracted, despite hemorrhoids being the third most common outpatient gastrointestinal diagnosis in the US, with nearly 4 million office and emergency department visits a year¹.

The 2023 systematic review does list constipation as a risk factor. Reviewing 44 publications, it reports risk factors for hemorrhoidal disease as sedentary behavior, constipation, male gender, and age².

So: constipation is commonly reported as a risk factor, and the causal chain from it to hemorrhoids has not actually been demonstrated. Both of those are true at once, and anyone telling you flatly that your GLP-1 gave you hemorrhoids is going past the evidence.

The two sources cited here did not study GLP-1 medications against this outcome. Not one of these sources looked at semaglutide or tirzepatide. What we know is that these drugs commonly cause constipation, and that constipation is associated with hemorrhoidal disease in some reviews. Joining those two facts into a claim about the drugs is an assumption, not a finding.

What the treatment evidence actually looks like

Thinner than I expected, and worth knowing before anyone sells you something.

The 2019 review described limited medical-treatment research and inconsistent fiber results¹. That is not a reason to skip it — fiber is doing other useful work for you if you are constipated — but it is a reason not to feel like a failure when it does not resolve everything.

One comparative finding did stand out. The 2023 review found that micronized purified flavonoid fractions significantly improved the main symptoms of hemorrhoidal disease compared with other pharmacological treatments². I am reporting that as the review reported it, not recommending it — that is a conversation for whoever is treating you.

Recurrence is common. Across 23 real-world studies it ranged from 0 to 56.5%, though most reported 20% or less².

Before agreeing to a procedure, I would ask why it fits the diagnosis, what alternatives exist, what recovery involves and what recurrence means in that setting. The review discusses office-based and surgical approaches, but it cannot select a procedure for an individual¹.

What I would actually do

Get bleeding assessed rather than assumed. This is the whole reason I wrote the page. Symptoms cannot distinguish hemorrhoids from other causes¹.

Treat the constipation as the upstream job. Whether or not it is causing the problem, straining is miserable and worth fixing on its own terms. I would bring the questions in the constipation piece to the prescribing team.

Do not power through pain. The instinct to cope quietly is the one that keeps women out of clinics. The other red lines — severe abdominal pain, a hard or swollen belly, vomiting — are in managing GLP-1 side effects.

Say the actual words at the appointment. "I have been constipated on this medication and I have had rectal bleeding" is one sentence and it gets you the right workup. It is a deeply unglamorous sentence. Say it anyway.

What I would take into the appointment

I would write down when bleeding began, how much I noticed, whether it is recurring and any pain or change in bowel habits. I would include the medication and dose timeline rather than decide that it supplies the diagnosis.

I would ask what examination is needed and what symptoms should trigger urgent help. I would also ask for a constipation plan that fits my intake and other medicines. The useful result is an explanation and follow-up, not permission to keep guessing every time I see blood.